NCT00147849

Brief Summary

The purpose of this study is to identify, from a societal perspective, the costs and associated benefits of three strategies for disseminating and implementing a practice guideline that addresses the management of croup.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2000

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2000

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2005

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
Last Updated

November 29, 2005

Status Verified

September 1, 2005

First QC Date

September 2, 2005

Last Update Submit

November 28, 2005

Conditions

Keywords

knowledge translationhealth care utilizationeconomic analysis

Outcome Measures

Primary Outcomes (1)

  • Rate of hospital days per 1,000 disease episodes

Secondary Outcomes (4)

  • Proportion of patients treated in the ED and hospital with a corticosteroid.

  • Proportion of patients evaluated in ED for at least three hours after treatment with corticosteroids before the decision to admit to hospital is made.

  • Time to treatment with corticosteroids in both ED and hospital patients.

  • An economic analysis conducted from a societal perspective with costs classified as either payer (costs born by the province) or non-payer (costs born by individuals or the families of children with croup).

Interventions

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Alberta hospitals were rank ordered based on the number of disease episodes and rates of hospitalization for a six-year period. We then approached in this order each of the hospital administrators and clinical staff for permission to include their hospital in our study until a total of 24 hospitals consented

You may not qualify if:

  • Refusal by hospital staff to participate in this trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CroupPatient Acceptance of Health Care

Condition Hierarchy (Ancestors)

LaryngitisLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • David W Johnson, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
ECT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 2, 2005

First Posted

September 7, 2005

Study Start

September 1, 2000

Study Completion

March 1, 2006

Last Updated

November 29, 2005

Record last verified: 2005-09